Unknown PHASE3 INTERVENTIONAL NCT00003578

High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma

A Randomized Trial to Evaluate Early High Dose Therapy and Autologous Bone Marrow Transplantation as Part of Planned Initial Therapy for Poor Risk Intermediate/High Grade NHL

Sponsor: Lymphoma Trials Office

Conditions Lymphoma

Interventions CHOP regimen autologous bone marrow transplantation carmustine cyclophosphamide cytarabine doxorubicin hydrochloride etoposide melphalan peripheral blood stem cell transplantation prednisone vincristine sulfate

Updated 6 times since 2017 Last updated: Sep 19, 2013 Started: Jan 31, 1993

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00003578, this PHASE3 trial focuses on Lymphoma and remains ongoing. Sponsored by Lymphoma Trials Office, it has been updated 6 times since 1993, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE3
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

Jan 1993

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lymphoma Trials Office

Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aarhus, Denmark , Aylesbury-Buckinghamshire, United Kingdom , Bangor, United Kingdom , Bath, United Kingdom , Belfast, United Kingdom , Birmingham, United Kingdom , Bournemouth, United Kingdom , Bristol, United Kingdom , Burton-on-Trent, United Kingdom , Canterbury, United Kingdom and 47 more locations